Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

207 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-12-09

Study Completion Date

2015-01-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An historical data comparator study for children with relapsed/refactory acute lymphoblastic leukemia (ALL).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)

NCT03743246

Precursor Cell Lymphoblastic Leukemia-Lymphoma Lymphoma, Non-Hodgkin

TERMINATED PHASE1/PHASE2

Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma

NCT01700946

Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia Recurrent Childhood B-Lymphoblastic Lymphoma

COMPLETED PHASE2

Treatment of Acute Lymphoblastic Leukemia in Children

NCT00165178

Acute Lymphoblastic Leukemia

COMPLETED PHASE3

International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010

NCT01802814

Acute Lymphoblastic Leukemia (ALL)

COMPLETED PHASE3

International Study for Treatment of High Risk Childhood Relapsed ALL 2010

NCT03590171

Acute Lymphoblastic Leukemia (ALL)

RECRUITING PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A retrospective observational study reviewing historical complete remission for pediatric patients who had either relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

B-cell Precursor Acute Lymphoblastic Leukemia (ALL)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All subjects

All subjects will be included in a unique cohort

Other: not applicable - observational study

Intervention Type OTHER

No intervention exists as this is a retrospective observational study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Other: not applicable - observational study

No intervention exists as this is a retrospective observational study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pediatric (age less than 18 years) patients with relapsed or refractory B-cell precursor ALL, specifically those with
* 2nd or later relapse after chemotherapy (with no prior transplantation),
* Relapse after HSCT, or
* Refractory disease
* Had treatment for relapsed or refractory disease between 2005-2012
* Has data available on ALL treatment, including number of salvage treatments, response status after therapies, and HSCT